Helicobacter pylori(H. pylori) infection has often no clinical signs and is one of the most common bacterial infections. All infected subjects have histology of active chronic gastritis. In some cases patients develop...Helicobacter pylori(H. pylori) infection has often no clinical signs and is one of the most common bacterial infections. All infected subjects have histology of active chronic gastritis. In some cases patients develop peptic ulcer and minority of them develop gastric cancer. Gastric cancer is multifactorial disease,thus various progressions of H. pylori infection and disease are dependent on the host genetic factors,the characteristics of the individual's immune response,environmental factors,and different bacterial virulence factors of the individual bacterial strains. Eradication of the bacteria plays a crucial role in the treatment of these cases however antibiotic therapy does not always help. Bacteria often develop resistance to antibiotics so we recommend that not only screening for H. pylori also the strain determination should have some diagnostic value,especially in the patients who already developed gastritis. Furthermore,for such patients assessment of disease progression(atrophic or metaplastic gastritis) could be followed by polymorphism determination. Until now we cannot predict the disease based only on single polymorphism. Bacteria successfully neutralize the responses of the immune systems using different enzymes or even components of the host immune response. However,the influence of immune system and its components could represent new ways of treatments and could help to eradicate the infection.展开更多
文摘Helicobacter pylori(H. pylori) infection has often no clinical signs and is one of the most common bacterial infections. All infected subjects have histology of active chronic gastritis. In some cases patients develop peptic ulcer and minority of them develop gastric cancer. Gastric cancer is multifactorial disease,thus various progressions of H. pylori infection and disease are dependent on the host genetic factors,the characteristics of the individual's immune response,environmental factors,and different bacterial virulence factors of the individual bacterial strains. Eradication of the bacteria plays a crucial role in the treatment of these cases however antibiotic therapy does not always help. Bacteria often develop resistance to antibiotics so we recommend that not only screening for H. pylori also the strain determination should have some diagnostic value,especially in the patients who already developed gastritis. Furthermore,for such patients assessment of disease progression(atrophic or metaplastic gastritis) could be followed by polymorphism determination. Until now we cannot predict the disease based only on single polymorphism. Bacteria successfully neutralize the responses of the immune systems using different enzymes or even components of the host immune response. However,the influence of immune system and its components could represent new ways of treatments and could help to eradicate the infection.
